Filgrastim Withdrawn Phase 2 Trials for Anemia / Chronic Myeloproliferative Disorders / Multiple Myeloma and Plasma Cell Neoplasm / Myelodysplastic/Myeloproliferative Diseases / Myelodysplastic Syndromes (MDS) / Malignant Lymphomas / Leukemias Treatment